203 related articles for article (PubMed ID: 36463916)
1. The current state of laboratory mycology and access to antifungal treatment in Europe: a European Confederation of Medical Mycology survey.
Salmanton-García J; Hoenigl M; Gangneux JP; Segal E; Alastruey-Izquierdo A; Arikan Akdagli S; Lagrou K; Özenci V; Vena A; Cornely OA
Lancet Microbe; 2023 Jan; 4(1):e47-e56. PubMed ID: 36463916
[TBL] [Abstract][Full Text] [Related]
2. The current state of laboratory mycology in Asia/Pacific: A survey from the European Confederation of Medical Mycology (ECMM) and International Society for Human and Animal Mycology (ISHAM).
Salmanton-García J; Au WY; Hoenigl M; Chai LYA; Badali H; Basher A; Brockhoff RA; Chen SC; Chindamporn A; Chowdhary A; Heath CH; Jabeen K; Lee J; Matar M; Taj-Aldeen SJ; Tan BH; Uno K; Wahyuningsih R; Zhu L; Chakrabarti A; Cornely OA
Int J Antimicrob Agents; 2023 Mar; 61(3):106718. PubMed ID: 36640851
[TBL] [Abstract][Full Text] [Related]
3. Multicentric Study on the Clinical Mycology Capacity and Access to Antifungal Treatment in Portugal.
Fernandes R; Sabino R; Cunha C; Cornely OA; Carvalho A; Salmanton-García J;
Mycopathologia; 2024 Jan; 189(1):15. PubMed ID: 38265528
[TBL] [Abstract][Full Text] [Related]
4. The current state of Clinical Mycology in Eastern and South-Eastern Europe.
Driemeyer C; Falci DR; Hoenigl M; Cornely OA; Chakrabarti A; Gangneux JP; Segal E; Jürna-Ellam M; Matos T; Meis JF; Perfect JR; Arsenijevic VA; Mares M; Serban DE; Pasqualotto AC
Med Mycol; 2022 Mar; 60(4):. PubMed ID: 35195256
[TBL] [Abstract][Full Text] [Related]
5. Laboratory and clinical management capacity for invasive fungal infections: the Italian landscape.
Vena A; Bassetti M; Mezzogori L; Marchesi F; Hoenigl M; Giacobbe DR; Corcione S; Bartoletti M; Stemler J; Pagano L; Cornely OA; Salmanton-García J
Infection; 2024 Feb; 52(1):197-208. PubMed ID: 37656348
[TBL] [Abstract][Full Text] [Related]
6. Improving awareness, diagnosis and management of invasive fungal infections in Ghana: establishment of the Ghana Medical Mycology Society.
Ocansey BK; Dadzie EA; Eduful SK; Agyei M; Osei MM; Puplampu P; Asamoah I; Oladele RO; Osaigbovo II; Afriyie-Mensah JS; Opintan JA; Essien-Baidoo S; Chakrabarti A; Hoenigl M; Denning DW; Richardson MD
Med Mycol; 2022 Sep; 60(9):. PubMed ID: 36073757
[TBL] [Abstract][Full Text] [Related]
7. Unveiling the Hungarian landscape of laboratory and clinical management capacities for invasive fungal infections: navigating the frontlines against fungal menaces.
Kovács R; Majoros L; Stemler J; Cornely OA; Salmanton-García J
Ther Adv Infect Dis; 2023; 10():20499361231219315. PubMed ID: 38116297
[TBL] [Abstract][Full Text] [Related]
8. The Argentinian landscape of mycological diagnostic capacity and treatment accessibility.
Riera F; Caeiro JP; Cornely OA; Salmanton-García J;
Med Mycol; 2023 Jun; 61(6):. PubMed ID: 37312404
[TBL] [Abstract][Full Text] [Related]
9. The current state of clinical mycology in Africa: a European Confederation of Medical Mycology and International Society for Human and Animal Mycology survey.
Driemeyer C; Falci DR; Oladele RO; Bongomin F; Ocansey BK; Govender NP; Hoenigl M; Gangneux JP; Lass-Flörl C; Cornely OA; Alanio A; Guinea J; Morrissey CO; Rautemaa-Richardson R; Chakrabarti A; Meis JF; Bruns C; Stemler J; Pasqualotto AC
Lancet Microbe; 2022 Jun; 3(6):e464-e470. PubMed ID: 35659908
[TBL] [Abstract][Full Text] [Related]
10. State of Medical Mycology at German Academic Medical Centres: A Survey of the German-Speaking Mycological Society (DMYKG) and the Paul-Ehrlich-Society for Chemotherapy (PEG).
Groll AH; Gordon K; Buchheidt D; Willinger B; Heinz WJ; Kurzai O; Rickerts V; Cornely OA;
Mycoses; 2021 Oct; 64(10):1177-1182. PubMed ID: 34180098
[TBL] [Abstract][Full Text] [Related]
11. The Austrian landscape of diagnostic capacity and access to treatment for invasive fungal infections.
Salmanton-García J; Hoenigl M; Salzer HJF; Lackner M; Prattes J; Dichtl K; Winkler-Zamani M; Krause R; Stemler J; Lass-Flörl C; Cornely OA; Willinger B
Mycoses; 2023 Dec; 66(12):1056-1063. PubMed ID: 37592370
[TBL] [Abstract][Full Text] [Related]
12. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
13. Defining breakthrough invasive fungal infection-Position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology.
Cornely OA; Hoenigl M; Lass-Flörl C; Chen SC; Kontoyiannis DP; Morrissey CO; Thompson GR;
Mycoses; 2019 Sep; 62(9):716-729. PubMed ID: 31254420
[TBL] [Abstract][Full Text] [Related]
14. The Nairobi Declaration 2023: A commitment to address deadly yet neglected fungal diseases in Africa.
Osaigbovo II; Govender NP; Jordan AM; Bongomin F; Meya DB; Kanyua A; Mashedi OM; Koffi D; Loyse A; Sturny-Leclère A; Gangneux JP; Denning DW; Chiller T; Cornely OA; Oladele RO
Med Mycol; 2024 Jan; 62(1):. PubMed ID: 38154488
[TBL] [Abstract][Full Text] [Related]
15. National mycology laboratory diagnostic capacity for invasive fungal diseases in 2017: Evidence of sub-optimal practice.
Schelenz S; Owens K; Guy R; Rautemaa-Richardson R; Manuel RJ; Richardson M; Moore C; Enoch DA; Micallef C; Howard P; Agrawal SG; Johnson EM; Muller-Pebody B;
J Infect; 2019 Aug; 79(2):167-173. PubMed ID: 31233810
[TBL] [Abstract][Full Text] [Related]
16. Clinicians' challenges in managing patients with invasive fungal diseases in seven Asian countries: An Asia Fungal Working Group (AFWG) Survey.
Tan BH; Chakrabarti A; Patel A; Chua MMM; Sun PL; Liu Z; Rotjanapan P; Li R; Wahyuningsih R; Chayakulkeeree M; Chen YC;
Int J Infect Dis; 2020 Jun; 95():471-480. PubMed ID: 31945491
[TBL] [Abstract][Full Text] [Related]
17. European confederation of medical mycology expert consult-An ECMM excellence center initiative.
Koehler P; Denis B; Denning DW; Gangneux JP; Hoenigl M; Kontoyiannis DP; Krause R; Lagrou K; Lass-Flörl C; Maertens J; Mareković I; Meis JF; Molina JM; Pleško S; Prattes J; Rath PM; Rautemaa-Richardson R; Richardson M; Segal E; Seidel D; Spriet I; Steinmann J; Verweij PE; Cornely OA;
Mycoses; 2020 Jun; 63(6):566-572. PubMed ID: 32181546
[TBL] [Abstract][Full Text] [Related]
18. Tolerability and outcome of once weekly liposomal amphotericin B for the prevention of invasive fungal infections in hematopoietic stem cell transplant patients with graft-versus-host disease.
Luu Tran H; Mahmoudjafari Z; Rockey M; Henry D; Grauer D; Aljitawi O; Abhyankar S; Ganguly S; Lin T; McGuirk J
J Oncol Pharm Pract; 2016 Apr; 22(2):228-34. PubMed ID: 25471252
[TBL] [Abstract][Full Text] [Related]
19. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.
Moen MD; Lyseng-Williamson KA; Scott LJ
Drugs; 2009; 69(3):361-92. PubMed ID: 19275278
[TBL] [Abstract][Full Text] [Related]
20. Improving outcome of fungal diseases - Guiding experts and patients towards excellence.
Cornely OA; Lass-Flörl C; Lagrou K; Arsic-Arsenijevic V; Hoenigl M
Mycoses; 2017 Jul; 60(7):420-425. PubMed ID: 28497502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
